One of the things I think I know is that multiple myeloma is often harder on caregivers than it is on the person with the disease.

To some, that may seem counter-intuitive. You’d probably consider that the person with the disease is the one confronting the harder road to travel on, but I believe such a perspective ignores the turmoil, the emotional roller-coaster. and the uncertainty that caregivers face.

I don’t mean to diminish the impact of what becomes an…

I was thinking the other day about mortality. By no means am I obsessed with this, but a thought process about one’s own mortality is, for me at least, sometimes unavoidable, given a life-shortening multiple myeloma diagnosis.

There doesn’t seem to be much written – there’s some – about the psychic impact of living with a disease that’s pretty much always fatal, and one where you don’t really have a clue when your myeloma will turn on you and go…

I don’t know about you, but I’m not too clear-headed about the appointment where I got my initial myeloma diagnosis.

First of all, I suppose I should have taken it as an ominous sign when the hematologist/oncologist’s office called me and asked if I could be there in an hour.

Basically, this is really all I recall:

We went into the exam room, and the doctor sat on his little wheeled stool. Linda (my wife) and I sat…

One of the universal bits of advice you’re going to get as a patient with multiple myeloma is that you need a good relationship with your doctor.

In a recent article, patient Kay Cromie of Burlington, Vermont, stressed to Myeloma Beacon writer Saniya Tabani the importance of developing a rapport with your doctor, so you can feel comfortable communicating your concerns, asking questions, and discussing treatment options with your doctor.

When I spoke a few weeks ago with Dr.…

Back in 2006, when I was initially diagnosed with myeloma, I learned of the interest among researchers in investigating maintenance therapies, particularly a Revlimid (lenalidomide)/dexamethasone (Decadron) combination.

This struck me at the time as an encouraging and exciting development, particularly for anyone who had paid attention to how a similar line of research and the introduction of protease inhibitors and combination therapies have changed the lives of many persons living with HIV/AIDS over the past 15 years.…